Eli Lilly & Co. (LLY)
997.21
-13.10
(-1.30%)
USD |
NYSE |
Dec 08, 16:00
995.50
-1.71
(-0.17%)
After-Hours: 20:00
Eli Lilly Shareholders Equity (Quarterly): 23.79B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Adverum Biotechnologies, Inc. | -55.65M |
| Viking Therapeutics, Inc. | 713.03M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.94B |
| Total Liabilities (Quarterly) | 91.08B |
| Debt to Equity Ratio | 1.786 |
| Current Ratio | 1.546 |
| Net Debt Paydown Yield | -0.40% |